alectinib - risultati della ricerca

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

alecensa 150 mg capsule rigide

roche pharma (schweiz) ag - alectinibum - capsule rigide - alectinibum 150 mg ut alectinibi hydrochloridum, lactosum monohydricum 33.67 mg, hydroxypropylcellulosum, natrii laurilsulfas corresp. natrium 6 mg, carmellosum calcicum, magnesii stearas, kapselhülle: carrageenanum, kalii chloridum, e 171, cera carnauba, maydis amylum, hypromellosum, drucktinte: e 172 (rubrum), e 172 (flavum), e 132, cera carnauba, lacca, polyglyceroli-3 mono-oleas, pro capsula. - non tumori polmonari a piccole carcinoma polmonare (nsclc) - synthetika

Unione Europea - italiano - EMA (European Medicines Agency)

alecensa

roche registration gmbh - alectinib cloridrato - carcinoma, polmone non a piccole cellule - agenti antineoplastici - alecensa in monoterapia è indicato per il trattamento di prima linea di pazienti adulti con carcinoma polmonare non a piccole cellule (nsclc) avanzato anaplastico-linfoma chinasi (alk) -positivo. alecensa come monoterapia è indicato per il trattamento di pazienti adulti con alk‑positivo nsclc avanzato precedentemente trattati con crizotinib.

Unione Europea - italiano - EMA (European Medicines Agency)

lorviqua

pfizer europe ma eeig - lorlatinib - carcinoma, polmone non a piccole cellule - antineoplastic agents, protein kinase inhibitors - lorviqua as monotherapy is indicated for the treatment of adult patients with anaplastic lymphoma kinase (alk)‑positive advanced non‑small cell lung cancer (nsclc) previously not treated with an alk inhibitor. lorviqua as monotherapy is indicated for the treatment of adult patients with alk‑positive advanced nsclc whose disease has progressed after:alectinib or ceritinib as the first alk tyrosine kinase inhibitor (tki) therapy; orcrizotinib and at least one other alk tki.

Unione Europea - italiano - EMA (European Medicines Agency)

lumeblue (previously known as methylthioninium chloride cosmo)

alfasigma s.p.a. - cloruro di metiltioninio - colorectal neoplasms; colonoscopy - other diagnostic agents - lumeblue is indicated as a diagnostic agent enhancing visualisation of colorectal lesions in adult patients undergoing screening or surveillance colonoscopy.